v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities:    
Net loss $ (51,728) $ (53,307)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 4,556 6,231
Gain on change in fair value of SAFE and warrant liabilities (3,184) (20,322)
Loss on change in fair value of the Brookfield Loan 12,445 0
Loss on Brookfield SAFE extinguishment 6,216 0
Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities 0 23,998
Change in fair value of Convertible Note (42,980) 0
Loss on change in fair value of PIPE Warrant liability 3,400 0
Loss on partial lease termination (60) 0
Provisions for losses on trade and other receivables, net of recoveries 126 (700)
Depreciation of property, plant and equipment 1,835 2,988
Amortization of discount on debt security investment (34) (501)
Non-cash lease expense 917 887
Non-cash recognition of licensing revenue (2,214) (9,240)
Loss from equity method investees, net 9,867 2,400
Unrealized (Gain)/Loss on net foreign exchange 649 (131)
Changes in operating assets and liabilities:    
Accounts receivable, net 2,334 3,575
Contract assets 11,231 1,034
Accrued interest on debt investment (83) 120
Other assets 1,377 (2,269)
Accounts payable and accrued salaries and wages (882) 458
Contract liabilities 61 128
Operating lease liabilities (877) 507
Other liabilities 4,213 1,202
Net cash used in operating activities (42,815) (42,942)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (879) (3,268)
Proceeds from maturity of debt securities 12,408 32,770
Net cash provided by investing activities 11,529 29,502
Cash Flows From Financing Activities:    
Proceeds from issuance of preferred stock 15,050 0
Issuance costs related to preferred stock (1,881) 0
Proceeds from issue of equity instruments of the Company 0 272
Repurchase of equity instruments of the Company 0 (48)
Partial settlement of the Brookfield Loan (12,500) 0
Proceeds from PIPE Warrant 24,950 0
Net cash provided by financing activities 25,619 224
Effects of currency translation on cash, cash equivalents and restricted cash (425) (177)
Net decrease in cash, cash equivalents and restricted cash (6,092) (13,393)
Cash, cash equivalents and restricted cash at beginning of period 45,737 76,284
Cash, cash equivalents and restricted cash at end of period 39,645 62,891
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment under accounts payable 106 235
Right-of-use asset additions 0 8,934
Cashless issuance of equity for Convertible Notes 8,132 0
Issuance of the Brookfield Loan 6,216 0
Non-cash change in lease liability on partial termination 13,025 0
Non-cash change in ROU assets on partial termination $ (13,085) $ 0